• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重主动脉瓣狭窄患者的冠状动脉疾病风险预测:主动脉瓣狭窄-冠状动脉疾病(AS-CAD)评分的制定和验证。

Coronary Artery Disease Risk Prediction in Patients With Severe Aortic Stenosis: Development and Validation of the Aortic Stenosis-Coronary Artery Disease (AS-CAD) Score.

机构信息

Department of Cardiology, Heart Centre, Alfred Health, Victoria, Australia.

Monash University, Faculty of Medicine, Nursing and Health Sciences, University in Clayton, Victoria, Australia.

出版信息

Am J Cardiol. 2023 Oct 15;205:134-140. doi: 10.1016/j.amjcard.2023.07.168. Epub 2023 Aug 18.

DOI:10.1016/j.amjcard.2023.07.168
PMID:37598598
Abstract

Patients at a low risk of coronary artery disease (CAD) could be triaged to noninvasive coronary computed tomography angiogram instead of invasive coronary angiography, reducing health care costs and patient morbidity. Therefore, we aimed to develop a CAD risk prediction score to identify those who underwent transcatheter aortic valve implantation (TAVI) at a low risk of CAD. We enrolled 1,782 patients who underwent TAVI and randomized the patients to the derivation or validation cohort 2:1. The aortic stenosis-CAD (AS-CAD) score was developed using logistic regression, followed by separation into low- (score 0 to 5), intermediate- (6 to 10), or high-risk (>11) categories. The AS-CAD was validated initially through the k-fold cross-validation, followed by a separately held validation cohort. The average age of the cohort was 82 ± 7 years, and 41% (730 of 1,782) were female; 35% (630) had CAD. The male sex, previous percutaneous coronary intervention, stroke, peripheral arterial disease, diabetes, smoking status, left ventricular ejection fraction <50%, and right ventricular systolic pressure >35 mm Hg were all associated with an increased risk of CAD and were included in the final AS-CAD model (all p <0.03). Within the validation cohort, the AS-CAD score stratified those into low, intermediate, and high risk of CAD (p <0.001). Discrimination was good within the internal validation cohort, with a c-statistic of 0.79 (95% confidence interval 0.74 to 0.84), with similar power obtained using k-fold cross-validation (c-statistic 0.74 [95% confidence interval 0.70 to 0.77]). In conclusion, The AS-CAD score robustly identified those at a low risk of CAD in patients with severe AS. The use of AS-CAD in practice could avoid potential complications of invasive coronary angiogram by triaging low-risk patients to noninvasive coronary assessment using existing computed tomography data.

摘要

患有低危冠心病(CAD)的患者可以通过非侵入性冠状动脉计算机断层扫描血管造影(CCTA)而非有创冠状动脉造影(ICA)进行分诊,从而降低医疗保健成本和患者发病率。因此,我们旨在开发一种 CAD 风险预测评分,以识别那些接受经导管主动脉瓣置换术(TAVI)的低危 CAD 患者。我们纳入了 1782 名接受 TAVI 的患者,并将患者随机分为推导队列和验证队列,比例为 2:1。使用逻辑回归开发了主动脉瓣狭窄-CAD(AS-CAD)评分,然后将其分为低危(评分 0 至 5 分)、中危(6 至 10 分)或高危(>11 分)类别。首先通过 k 折交叉验证验证 AS-CAD,然后在单独的验证队列中进行验证。队列的平均年龄为 82±7 岁,41%(730 名/1782 名)为女性;35%(630 名)患有 CAD。男性、经皮冠状动脉介入治疗、中风、外周动脉疾病、糖尿病、吸烟状况、左心室射血分数<50%和右心室收缩压>35mmHg 均与 CAD 风险增加相关,并包含在最终的 AS-CAD 模型中(所有 p<0.03)。在验证队列中,AS-CAD 评分将患者分为 CAD 低危、中危和高危(p<0.001)。内部验证队列的区分度较好,C 统计量为 0.79(95%置信区间 0.74 至 0.84),使用 k 折交叉验证也获得了相似的效果(C 统计量 0.74[95%置信区间 0.70 至 0.77])。总之,AS-CAD 评分可稳健地识别出严重主动脉瓣狭窄患者中 CAD 低危患者。在实践中,AS-CAD 的使用可以通过将低危患者分诊至现有的 CT 数据进行非侵入性冠状动脉评估,从而避免有创冠状动脉造影的潜在并发症。

相似文献

1
Coronary Artery Disease Risk Prediction in Patients With Severe Aortic Stenosis: Development and Validation of the Aortic Stenosis-Coronary Artery Disease (AS-CAD) Score.严重主动脉瓣狭窄患者的冠状动脉疾病风险预测:主动脉瓣狭窄-冠状动脉疾病(AS-CAD)评分的制定和验证。
Am J Cardiol. 2023 Oct 15;205:134-140. doi: 10.1016/j.amjcard.2023.07.168. Epub 2023 Aug 18.
2
Diagnostic performance of quantitative coronary artery disease assessment using computed tomography in patients with aortic stenosis undergoing transcatheter aortic-valve implantation.使用计算机断层扫描定量评估主动脉瓣狭窄行经导管主动脉瓣植入术患者的冠状动脉疾病的诊断性能。
BMC Cardiovasc Disord. 2022 Apr 18;22(1):178. doi: 10.1186/s12872-022-02623-8.
3
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术患者稳定型冠状动脉疾病的血运重建管理。
Circ Cardiovasc Interv. 2022 Dec;15(12):e012417. doi: 10.1161/CIRCINTERVENTIONS.122.012417. Epub 2022 Dec 20.
4
Percutaneous Coronary Intervention of Complex Calcific Coronary Lesions Utilizing Orbital Atherectomy Prior to Transcatheter Aortic Valve Replacement.经皮冠状动脉介入术治疗复杂钙化冠状动脉病变,在经导管主动脉瓣置换术之前使用轨道旋磨术。
Cardiovasc Revasc Med. 2022 Apr;37:82-85. doi: 10.1016/j.carrev.2021.06.117. Epub 2021 Jun 22.
5
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.经导管主动脉瓣植入术高危患者的冠状动脉疾病及合理不完全冠状动脉血运重建
Catheter Cardiovasc Interv. 2020 Jan;95(1):19-27. doi: 10.1002/ccd.28211. Epub 2019 Mar 27.
6
Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.经导管主动脉瓣植入术后冠状动脉疾病对左心室射血分数恢复的影响。
Catheter Cardiovasc Interv. 2015 Feb 15;85(3):450-8. doi: 10.1002/ccd.25632. Epub 2014 Aug 28.
7
CT angiography to evaluate coronary artery disease and revascularization requirement before trans-catheter aortic valve replacement.经导管主动脉瓣置换术前评估冠状动脉疾病和血运重建需求的 CT 血管造影。
J Cardiovasc Comput Tomogr. 2017 Sep-Oct;11(5):338-346. doi: 10.1016/j.jcct.2017.06.001. Epub 2017 Jun 22.
8
Coronary Artery Disease Assessed by Computed Tomography-Based Leaman Score in Patients With Low-Risk Transcatheter Aortic Valve Implantation.基于 Leaman 评分的计算机断层扫描评估低危经导管主动脉瓣植入患者的冠状动脉疾病。
Am J Cardiol. 2020 Apr 15;125(8):1216-1221. doi: 10.1016/j.amjcard.2020.01.022. Epub 2020 Jan 28.
9
Percutaneous coronary intervention or medical therapy in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve implantation: a real-world analysis using data from an international network.行经导管主动脉瓣置换术的严重主动脉瓣狭窄合并冠状动脉疾病患者中行经皮冠状动脉介入治疗或药物治疗:来自国际网络数据的真实世界分析。
Coron Artery Dis. 2023 Mar 1;34(2):134-137. doi: 10.1097/MCA.0000000000001215. Epub 2023 Jan 4.
10
Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.经导管主动脉瓣植入术患者的合并冠状动脉疾病及其管理:来自POL-TAVI注册研究的见解
Catheter Cardiovasc Interv. 2018 Jan 1;91(1):115-123. doi: 10.1002/ccd.27251. Epub 2017 Aug 26.

引用本文的文献

1
Co-Occurrence of Aortic Stenosis and Coronary Artery Disease: Facing Challenges Before, During, and After Transcatheter Aortic Valve Replacement.主动脉瓣狭窄与冠状动脉疾病的共病:经导管主动脉瓣置换术前、术中和术后面临的挑战
J Clin Med. 2025 Jul 3;14(13):4709. doi: 10.3390/jcm14134709.
2
Pre-interventional renal artery calcification and survival after transcatheter aortic valve implantation.经导管主动脉瓣植入术前肾动脉钙化与生存情况
Int J Cardiovasc Imaging. 2025 Jan;41(1):113-122. doi: 10.1007/s10554-024-03295-5. Epub 2024 Dec 7.
3
Association of socioeconomic status with clinical characteristics, care quality and outcomes in patients undergoing transcatheter aortic valve implantation.
经导管主动脉瓣植入术患者的社会经济地位与临床特征、护理质量及预后的关联
Int J Cardiol Heart Vasc. 2024 Nov 21;55:101561. doi: 10.1016/j.ijcha.2024.101561. eCollection 2024 Dec.
4
Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients.评估门诊患者中熊去氧胆酸对新型冠状病毒肺炎的保护效果及危险因素。
Front Pharmacol. 2024 Jul 31;15:1381830. doi: 10.3389/fphar.2024.1381830. eCollection 2024.